HIGHLIGHTS
- who: Adverse events following first et al. from the University of Oxford, Oxford, United Kingdom have published the paper: Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study, in the Journal: (JOURNAL) of 23/02/2022
- what: The analysis compares the incidence of medically attended AEIs following COVID-19 vaccination to background levels in 781,200 individuals.
- how: The authors conducted separate SCCS models for the three brands of vaccines. The authors carried out a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.